Canaccord Genuity reiterated their buy rating on shares of Senseonics Holdings Inc (NASDAQ:SENS) in a research note released on Thursday morning.

Separately, Zacks Investment Research lowered shares of Senseonics Holdings from a hold rating to a sell rating in a research report on Wednesday, August 9th.

Shares of Senseonics Holdings (NASDAQ SENS) opened at 3.19 on Thursday. Senseonics Holdings has a 1-year low of $2.15 and a 1-year high of $3.94. The stock has a 50 day moving average of $3.09 and a 200 day moving average of $3.09. The stock’s market cap is $393.01 million.

Senseonics Holdings (NASDAQ:SENS) last released its earnings results on Wednesday, August 9th. The company reported ($0.12) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.13) by $0.01. The business had revenue of $0.81 million during the quarter, compared to analyst estimates of $0.81 million. Equities research analysts forecast that Senseonics Holdings will post ($0.54) EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Canaccord Genuity Reaffirms Buy Rating for Senseonics Holdings Inc (SENS)” was first reported by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://www.watchlistnews.com/canaccord-genuity-reaffirms-buy-rating-for-senseonics-holdings-inc-sens/1602685.html.

In other Senseonics Holdings news, COO Mukul Jain sold 13,115 shares of the firm’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $3.25, for a total value of $42,623.75. Following the transaction, the chief operating officer now directly owns 13,115 shares of the company’s stock, valued at $42,623.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. NEA Management Company LLC increased its stake in Senseonics Holdings by 27.1% during the 2nd quarter. NEA Management Company LLC now owns 33,425,275 shares of the company’s stock worth $60,165,000 after buying an additional 7,119,989 shares during the period. Blackstone Group L.P. acquired a new position in shares of Senseonics Holdings in the first quarter worth about $614,000. HarbourVest Partners LLC acquired a new position in shares of Senseonics Holdings in the first quarter worth about $470,000. Raymond James Financial Services Advisors Inc. lifted its stake in shares of Senseonics Holdings by 221.4% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 263,562 shares of the company’s stock worth $474,000 after acquiring an additional 181,562 shares in the last quarter. Finally, Goldman Sachs Group Inc. acquired a new position in shares of Senseonics Holdings in the second quarter worth about $276,000.

Senseonics Holdings Company Profile

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.